@article{3cd6de5657304d5d9bfde10a0ffa4bae,
title = "Editorial: Toward Personalized Treatment for Systemic Juvenile Idiopathic Arthritis",
author = "Vastert, \{Sebastiaan J.\} and Nigrovic, \{Peter A.\}",
note = "Funding Information: Dr. Vastert has received consulting fees from Novartis (less than \$10,000) and a research grant from ZonMW (co-funded by Sobi). Dr. Nigrovic has received consulting fees from Sobi, Novartis, Casebia, Pfizer, and UCB (less than \$10,000 each), royalties from UpToDate and the American Academy of Pediatrics, and research grants from AbbVie, Novartis, and Sobi. Funding Information: Dr. Vastert{\textquoteright}s work was supported by the Dutch Arthritis Foundation (grant LLP10) and ZonMW (Dutch Scientific Organisation, Rational Pharmacotherapy program). Dr. Nigrovic{\textquoteright}s work was supported by the NIH (grants R01-AR-065538 and P30-AR-070253), the Rheumatology Research Foundation (Disease Targeted Research Award), and by Fundaci{\'o}n Bechara.",
year = "2018",
month = aug,
day = "1",
doi = "10.1002/art.40501",
language = "English",
volume = "70",
pages = "1172--1174",
journal = "Arthritis and Rheumatology",
issn = "2326-5191",
publisher = "John Wiley \& Sons Inc.",
number = "8",
}